05:06 PM EDT, 07/11/2025 (MT Newswires) -- Jude Onyia, Chief Scientific Officer, on July 09, 2025, sold 59,819 shares in Neurocrine Biosciences ( NBIX ) for $7,803,688. Following the Form 4 filing with the SEC, Onyia has control over a total of 18,289 common shares of the company, with 18,289 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/914475/000091447525000151/xslF345X05/wk-form4_1752267655.xml